Antihepatoma Activity of Multifunctional Polymeric Nanoparticles Via Inhibition of Microtubules and Tyrosine Kinases

References

• Siegel R , MaJ, ZouZ, JemalA. Cancer statistics. CA Cancer J. Clin.64(1), 9–29 (2014).
   PubMed Web of Science ®Google Scholar
• Yang JD , RobertsLR. Hepatocellular carcinoma: a global view. Nat. Rev. Gastroenterol. Hepatol.7(8), 448–458 (2010).
   PubMed Web of Science ®Google Scholar
• Terry K , CopurMS. Molecular targeted therapy of hepatocellular carcinoma. J. Cancer Ther.4(2), 426–439 (2013).
   Google Scholar
• Choe MS , ChenZ, KlassCM, ZhangX, ShinDM. Enhancement of docetaxel-induced cytotoxicity by blocking epidermal growth factor receptor and cyclooxygenase-2 pathways in squamous cell carcinoma of the head and neck. Clin. Cancer Res.13(10), 3015–3023 (2007).
   PubMed Web of Science ®Google Scholar
• Herbst RS , KhuriFR. Mode of action of docetaxel – a basis for combination with novel anticancer agents. Cancer Treat. Rev.29(5), 407–415 (2003).
   PubMed Web of Science ®Google Scholar
• Seligmann J , TwelvesC. Tubulin: an example of targeted chemotherapy. Future Med. Chem.5(3), 339–352 (2013).
   PubMed Web of Science ®Google Scholar
• Dumontet C , JordanMA. Microtubule-binding agents: a dynamic field of cancer therapeutics. Nat. Rev. Drug Discov.9(10), 790–803 (2010).
   PubMed Web of Science ®Google Scholar
• Zhang J , YangPL, GrayNS. Targeting cancer with small molecule kinase inhibitors. Nat. Rev. Cancer.9(1), 28–39 (2009).
   PubMed Web of Science ®Google Scholar
• Wilhelm S , CarterC, LynchMet al. Discovery and development of sorafenib: a multikinase inhibitor for treating cancer. Nat. Rev. Drug Discov.5(10), 835–844 (2006).
   PubMed Web of Science ®Google Scholar
• Baker J , AjaniJ, ScottéFet al. Docetaxel-related side effects and their management. Eur. J. Oncol. Nurs.13(1), 49–59 (2009).
   PubMed Web of Science ®Google Scholar
• Montero A , FossellaF, HortobagyiG, ValeroV. Docetaxel for treatment of solid tumours: a systematic review of clinical data. Lancet Oncol.6(4), 229–239 (2005).
   PubMed Web of Science ®Google Scholar
• Baker SD , ZhaoM, LeeCKet al. Comparative pharmacokinetics of weekly and every-three-weeks docetaxel. Clin. Cancer Res.10(6), 1976–1983 (2004).
   PubMed Web of Science ®Google Scholar
• Morabito A , DeMaio E, DiMaio M, NormannoN, PerroneF. Tyrosine kinase inhibitors of vascular endothelial growth factor receptors in clinical trials: current status and future directions. Oncologist.11(7), 753–764 (2006).
   PubMed Web of Science ®Google Scholar
• Wilhelm SM , AdnaneL, NewellP, VillanuevaA, LlovetJM, LynchM. Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling. Mol. Cancer Ther.7(10), 3129–3140 (2008).
   PubMed Web of Science ®Google Scholar
• Almhanna K , PhilipPA. Safety and efficacy of sorafenib in the treatment of hepatocellular carcinoma. Onco. Targets Ther.2, 261–267 (2009).
   PubMed Web of Science ®Google Scholar
• Lacouture ME , ReillyLM, GeramiP, GuitartJ. Hand foot skin reaction in cancer patients treated with the multikinase inhibitors sorafenib and sunitinib. Ann. Oncol.19(11), 1955–1961 (2008).
   PubMed Web of Science ®Google Scholar
• Carr BI , CarrollS, MuszbekN, GondekK. Economic evaluation of sorafenib in unresectable hepatocellular carcinoma. J. Gastroenterol. Hepatol.25(11), 1739–1746 (2010).
   PubMed Web of Science ®Google Scholar
• Shin HC , AlaniAW, RaoDA, RockichNC, KwonGS. Multi-drug loaded polymeric micelles for simultaneous delivery of poorly soluble anticancer drugs. J. Control. Rel.140(3), 294–300 (2009).
   PubMed Web of Science ®Google Scholar
• Liu Y , FengL, LiuTet al. Multifunctional pH-sensitive polymeric nanoparticles for theranostics evaluated experimentally in cancer. Nanoscale6(6), 3231–3242 (2014).
   PubMed Web of Science ®Google Scholar
• Avgoustakis K . Pegylated poly(lactide) and poly(lactide-co-glycolide) nanoparticles: preparation, properties and possible applications in drug delivery. Curr. Drug Deliv.1(4), 321–333 (2004).
   PubMedGoogle Scholar
• Kamaly N , XiaoZ, ValenciaPM, Radovic-MorenoAF, FarokhzadOC. Targeted polymeric therapeutic nanoparticles: design, development and clinical translation. Chem. Soc. Rev.41(7), 2971–3010 (2012).
   PubMed Web of Science ®Google Scholar
• ClinicalTrials.gov (2015). https://clinicaltrials.gov/ct2/show/NCT01792479
   Google Scholar
• Musumeci T , VenturaCA, GiannoneIet al. PLA/PLGA nanoparticles for sustained release of docetaxel. Int. J. Pharm.325(1–2), 172–179 (2006).
   PubMedGoogle Scholar
• Liu Y , LiK, PanJ, LiuB, FengSS. Folic acid conjugated nanoparticles of mixed lipid monolayer shell and biodegradable polymer core for targeted delivery of Docetaxel. Biomaterials.31(2), 330–338 (2010).
   PubMed Web of Science ®Google Scholar
• Agrawal R , ShanavasA, YadavS, AslamM, BahadurD, SrivastavaR. Polyelectrolyte coated polymeric nanoparticles for controlled release of docetaxel. J. Biomed. Nanotechnol.8(1), 19–28 (2012).
   PubMed Web of Science ®Google Scholar
• Roy A , MurakamiM, ErnstingMJ, HoangB, UndzysE, LiSD. Carboxymethylcellulose-based and docetaxel-loaded nanoparticles circumvent P-glycoprotein-mediated multidrug resistance. Mol. Pharm.11(8), 2592–2599 (2014).
   PubMedGoogle Scholar
• Zhang X , YangY, LiangXet al. Enhancing therapeutic effects of docetaxel-loaded dendritic copolymer nanoparticles by co-treatment with autophagy inhibitor on breast cancer. Theranostics4(11), 1085–1095 (2014).
   PubMed Web of Science ®Google Scholar
• Hrkach J , Von HoffD, MukkaramAli Met al. Preclinical development and clinical translation of a PSMA-targeted docetaxel nanoparticle with a differentiated pharmacological profile. Sci. Transl. Med.4(128), 128–139 (2012).
   Web of Science ®Google Scholar
• Zhang L , GongF, ZhangF, MaJ, ZhangP, ShenJ. Targeted therapy for human hepatic carcinoma cells using folate-functionalized polymeric micelles loaded with superparamagnetic iron oxide and sorafenib in vitro. Int. J. Nanomed.8, 1517–1524 (2013).
   PubMed Web of Science ®Google Scholar
• Poojari R , KiniS, SrivastavaR, PandaD. Intracellular interactions of electrostatically mediated layer-by-layer assembled polyelectrolytes based sorafenib nanoparticles in oral cancer cells. Colloids Surf. B.143, 131–138 (2016).
   PubMed Web of Science ®Google Scholar
• Wu X , LiuH, LiuJet al. Immunofluorescent labeling of cancer marker Her2 and other cellular targets with semiconductor quantum dots. Nat. Biotechnol.21(1), 41–46 (2003).
   PubMed Web of Science ®Google Scholar
• Saran AD , SadawanaMM, SrivastavaR, BellareJR. An optimized quantum dot-ligand system for biosensing applications: evaluation as a glucose biosensor. Colloids Surf. A: Physicochem. Eng. Asp.384(1–3), 393–400 (2011).
   Web of Science ®Google Scholar
• May A , BhaumikS, GambhirSS, ZhanC, YazdanfarS. Whole-body, real-time preclinical imaging of quantum dot fluorescence with time-gated detection. J. Biomed. Opt.14(6), 060504 (2009).
   PubMed Web of Science ®Google Scholar
• Zhang LW , Monteiro-RiviereNA. Mechanisms of quantum dot nanoparticle cellular uptake. Toxicol. Sci.110(1), 38–55 (2009).
   Web of Science ®Google Scholar
• Muthu MS , KulkarniSA, RajuA, FengSS. Theranostic liposomes of TPGS coating for targeted co-delivery of docetaxel and quantum dots. Biomaterials33(12), 3494–3501 (2012).
   PubMed Web of Science ®Google Scholar
• Dubertret B , SkouridesP, NorrisDJ, NoireauxV, BrivanlouAH, LibchaberA. In vivo imaging of quantum dots encapsulated in phospholipid micelles. Science298 (5599), 1759–1762 (2002).
   Web of Science ®Google Scholar
• Poojari R , KiniS, SrivastavaR, PandaD. A chimeric cetuximab-functionalized corona as a potent delivery system for microtubule-destabilizing nanocomplexes to hepatocellular carcinoma cells: a focus on EGFR and tubulin intracellular dynamics. Mol. Pharm.12(11), 3908–3923 (2015).
   PubMedGoogle Scholar
• Vichai V , KirtikaraK. Sulforhodamine B colorimetric assay for cytotoxicity screening. Nat. Protoc.1(3), 1112–1116 (2006).
   PubMed Web of Science ®Google Scholar
• Hura N , SawantAV, KumariA, GuchhaitSK, PandaD. Combretastatin-inspired heterocycles as antitubulin anticancer agents. ACS Omega.3, 9754–9769 (2018).
   PubMed Web of Science ®Google Scholar
• Franken NA , RodermondHM, StapJ, HavemanJ, Van BreeC. Clonogenic assay of cells in vitro. Nat. Protoc.1(5), 2315–2319 (2006).
   PubMed Web of Science ®Google Scholar
• Munshi A , HobbsM, MeynRE. In: Chemosensitivity: In Vitro Assays (Volume 1).BlumenthalRD ( Ed.). Humana Press, NJ, USA, Chapter 2, 21–28 (2005).
   Google Scholar
• Arnaoutova I , KleinmanHK. In vitro angiogenesis: endothelial cell tube formation on gelled basement membrane extract. Nat. Protoc.5(4), 628–635 (2010).
   PubMed Web of Science ®Google Scholar
• Sun D , LiuY, YuQ, ZhouY, ZhangR, ChenX. The effects of luminescent ruthenium(II) polypyridyl functionalized selenium nanoparticles on bFGF-induced angiogenesis and AKT/ERK signaling. Biomaterials34(1), 171–80 (2013).
   PubMed Web of Science ®Google Scholar
• Sonntag R , GasslerN, BangenJM, TrautweinC, LiedtkeC. Pro-apoptotic Sorafenib signaling in murine hepatocytes depends on malignancy and is associated with PUMA expression in vitro and in vivo. Cell Death Dis.5, e1030 (2014).
   PubMed Web of Science ®Google Scholar
• Xiong YQ , SunHC, ZhangWet al. Human hepatocellular carcinoma tumor-derived endothelial cells manifest increased angiogenesis capability and drug resistance compared with normal endothelial cells. Clin. Cancer Res.15(15), 4838–4846 (2009).
   PubMed Web of Science ®Google Scholar
• Abou-Alfa GK , SchwartzL, RicciSet al. Phase II study of sorafenib in patients with advanced hepatocellular carcinoma. J. Clin. Oncol.24(26), 4293–4300 (2006).
   PubMed Web of Science ®Google Scholar
• Schmidt CM , McKillopIH, CahillPA, SitzmannJV. Increased MAPK expression and activity in primary human hepatocellular carcinoma. Biochem. Biophys. Res. Commun.236(1), 54–58 (1997).
   PubMed Web of Science ®Google Scholar
• Xie B , WangDH, SpechlerSJ. Sorafenib for treatment of hepatocellular carcinoma: a systematic review. Dig. Dis. Sci.57(5), 1122–1129 (2012).
   PubMed Web of Science ®Google Scholar
• Huynh H , DoPT, NguyenTHet al. Extracellular signal-regulated kinase induces cyclin D1 and Cdk-2 expression and phosphorylation of retinoblastoma in hepatocellular carcinoma. Int. J. Oncol.25(6), 1839–1847 (2004).
   PubMed Web of Science ®Google Scholar
• Bisteau X , CaldezMJ, KaldisP. The complex relationship between liver cancer and the cell cycle: a story of multiple regulations. Cancers (Basel)6(1), 79–111 (2014).
   PubMed Web of Science ®Google Scholar
• Poojari R , PandaD, SrivastavaR. Multifunctional polymeric nanocarrier. Indian Patent Granted No. 317866 (2019).
   Google Scholar
• Poojari R , SrivastavaR, PandaD. Molecular intersection of a 3-in-1 nanomedicine targeting microtubules, ERK tyrosine kinases with profound nuclear modulations, and quantum imaging for hepatocellular carcinoma therapy. Presented at: Proceedings of the American Association for Cancer Research Annual Meeting.Washington, DC (1–5 April 2017).
   Google Scholar